Linagliptin + Metformin
Composition
This formulation contain combination of Linagliptin and Metformin as active agents
Indications
used to manage blood sugar levels in adults with type 2 diabetes mellitus
Side effects
gastrointestinal disturbances (such as nausea, vomiting, diarrhea, or abdominal discomfort), headache, and hypoglycemia
Precautions
Patients with kidney impairment, liver disease, or a history of lactic acidosis should use this combination Formulation with caution
Contraindications
severe kidney impairment or metabolic acidosis
Dosage and administration
directed by a healthcare professional
Countries
Available Forms
Tablet